Supporting female founder initiatives across the UK & Ireland

Find out more  
← Back to portfolio Porfolio / Arcinova


Pharmaceutical research and development company

Company overview

Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.


This is an exciting time for Arcinova. We have a fantastic team,​ a world-class facility and strong market opportunity. ​We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on​ a period of capital expenditure and international expansion.

Professor Ian Shott​, executive chair

Company information

Head office
  • Alnwick, Northumberland
  • Professor Ian Shott
BGF office
Investment date
  • Jun 2018 - Feb 2021
Total BGF investment
  • £5 million